FranTech Signs Agreement with NanoSignal

BROWSE BY CATEGORY

Health

Resources, Weight Loss

Business

Computers

Entertainment

Games

Home

Science

Sports

Society

Teens

Health - Medicine - FranTech International Licensing, Inc.

Release Date: November 18, 2005

FranTech Signs Agreement with NanoSignal

By FranTech International Licensing, Inc.
November 18, 2005

SEND

PDF

CONTACT

FranTech International Licensing, Inc. Announces International Franchising Agreement With NanoSignal Corporation

PR9.NET November 18, 2005 - VENTURA, California. NanoSignal Corp, an OTC Pink Sheet fully reporting company, symbol NNOS.OBPK, announced today that it has entered into an international licensing and franchising agreement with FranTech International Licensing, Inc. of Ventura, California.

Under the agreement FranTech will promote licenses and franchises in 220 countries. The licensees and franchises will have the right to market NanoSignal Corporation products including their proprietary SLICES™ technology.

"This represents the next step in the global development of the company," said NanoSignal President, Kelly Slade. "FranTech is the leader in international licensing and franchising opportunities worldwide.

"Over the next few months, NanoSignal will be establishing relationships with several other medical technology companies in joint marketing programs through FranTech licensing.
This will further enhance NanoSignal's position in the global market and will provide new revenue streams for the company", reported Dr. Rupert Perrin, NanoSignal Chairman of the Board.

The company explained that FranTech's mission is to foster the development of the global economy by providing a global perspective to developers, marketers, manufacturers and innovators on newly emerging and preemptive technologies. They offer world-class solutions for the licensing and transfer of USA innovations to emerging economies.

Philip Nadeau, CEO of FranTech, said, "We see a tremendous market worldwide for NanoSignal's products including its proprietary Slices™ technology and already have interest from several countries. We plan on developing brand name recognition and positioning of NanoSignal with many governmental agencies where we already have relationships in place."

# # #

Download PDF Version:
FranTech Signs Agreement with NanoSignal

Contact Information of FranTech International Licensing, Inc.

Phone	(805) 653-5264
FAX	(805) 643-4386
Website	http://www.FranTechUSA.com
E-Mail	E-mail Address Protected
Address	2299 East Main Street, Suite 11 Ventura, CA 93001 USA

About NanoSignal Corporation

NanoSignal is involved in the development and interface of state-of-the-art MRI data processing tools that provide significant processing and patient advantages compared to the other imaging software of its genre. NanoSignal is dedicated to promoting state-of-the data processing technologies to people from all ends of the globe.

The focus of NanoSignal is to develop technology, such as SLICES™, generating high quality images with low resolution raw data matrices, which allows for reduced patient scan times and more accurate diagnosis based upon the results. NanoSignal is uniquely positioned to address the MRI data processing needs of developing nations and industrial nations around the world.

About FranTech International Licensing, Inc.

FranTech consists of core partners surrounded by interlocking networks of consultants and affiliates in key trading countries and disciplines. They have over thirty-five years of experience with their proven partners. In addition, FranTech has proven track records in assembling, negotiating and consummating trade, licensing, franchising, technological transfer and financial agreements. They pool strengths drawn from experience in international securities and trade policy, insurance, law, marketing, investment banking and technology research. This broad expertise, coupled with access to key governmental and business decision makers, provides services uniquely valuable to their clients in the restructuring global economy.